Delivery Order SPE2DP20D0002-SPE2DP24F2013
Award Date 1/25/24
Potential Completion Date 1/30/24
Potential Value $318K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- The U.S. Defense Logistics Agency (DLA) awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $317,609.46 Delivery Order contract for the supply of Adenovirus Type 4 vaccines. This order falls under DLA Troop Support Medical's larger portfolio of contracts supporting military immunization programs. The contract has a firm fixed-price, with a completion date of June 25, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drugs and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm fixed-price delivery order (SPE2DP24F7177) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This order is part of a larger Indefinite Delivery Contract (SPE2DP20D0002) held by Teva to provide essential medications to federal agencies such as the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This vaccine supports military immunization programs. The contract has a completion date of July 30, 2024 and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. serves as a major supplier of critical drug products to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,270,437.84 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc. to provide Adenovirus Type 4 vaccines. Teva is a large, foreign-owned pharmaceutical manufacturer that has fulfilled numerous federal contracts for critical medical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs for agencies such as the Department of Veterans Affairs (VA) and Department of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. This delivery order has a completion date of January 30, 2024. Teva Pharmaceuticals USA, Inc. is the prime contractor and there is no set-aside designation for this award. The company has previously fulfilled multiple federal contracts and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccines. This contract has a period of performance through May 21, 2024. Teva Pharmaceuticals USA, Inc. has provided Adenovirus Type 4 vaccines to the DLA Troop Support Medical through numerous previous delivery order awards, typically ranging...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. The $146,823.93 order is not set aside and has a completion date of July 26, 2022. Teva has previously received numerous delivery orders from the Defense Logistics Agency to supply adenovirus vaccines and other pharmaceutical products such as albuterol inhalers to federal...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $158,804.73 firm-fixed-price delivery order contract (SPE2DP20D0002|SPE2DP24F3909) to provide Adenovirus Type 4 vaccines. The contract has an ultimate completion date of April 30, 2024 and is an unrestricted award, not set aside for any specific business type. Teva Pharmaceuticals USA, Inc. currently holds several major indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This contract, which has a completion date of May 21, 2024, supports military immunization programs. Teva Pharmaceuticals USA, Inc. has a long history of supplying critical pharmaceuticals, including other vaccines and medications, to various federal...